ondansetron has been researched along with Craniofacial Abnormalities in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Craniofacial Abnormalities: Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Postoperative vomiting is a common occurrence that can delay recovery and result in cerebrospinal fluid leak and fistula formation in these patients." | 2.69 | Prophylactic use of ondansetron for emesis after craniofacial operations in children. ( Celik, N; Gürler, T; Sakarya, M; Songür, E; Totan, S, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gürler, T | 1 |
| Celik, N | 1 |
| Totan, S | 1 |
| Songür, E | 1 |
| Sakarya, M | 1 |
1 trial available for ondansetron and Craniofacial Abnormalities
| Article | Year |
|---|---|
Prophylactic use of ondansetron for emesis after craniofacial operations in children.
Topics: Antiemetics; Child; Craniofacial Abnormalities; Craniotomy; Double-Blind Method; Humans; Ondansetron | 1999 |